Please login to the form below

Not currently logged in
Email:
Password:

neurological disorders

This page shows the latest neurological disorders news and features for those working in and with pharma, biotech and healthcare.

Biogen reveals new data for MS therapies Tysabri and Vumerity

Biogen reveals new data for MS therapies Tysabri and Vumerity

Researchers analysed patient-reported data on 12 different domains on the Neuro-QoL (Quality of Life in Neurological Disorders) questionnaire to ‘better understand clinically meaningful quality of life benefits’ following Tysabri

Latest news

More from news
Approximately 2 fully matching, plus 44 partially matching documents found.

Latest Intelligence

  • Pharma deals during December 2012 Pharma deals during December 2012

    an upfront of $30m, to discover and co-develop antisense drugs to treat three neurological or neuromuscular disorders. In January 2012, Biogen Idec paid Isis an upfront of $29m for an

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....